Novo Nordisk said Friday that its investigational anti-inflammatory drug did not reduce the risk of...
Novo Nordisk inflammation-targeting drug misses mark in heart disease study
Novo Nordisk said Friday that its investigational anti-inflammatory drug did not reduce the risk of major heart events in a pivotal trial, raising questions...
Author: STAT
Read Original Article